Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 207

1.

The influence of Apolipoprotein E genotype on regional pathology in Alzheimer's disease.

Sabbagh MN, Malek-Ahmadi M, Dugger BN, Lee K, Sue LI, Serrano G, Walker DG, Davis K, Jacobson SA, Beach TG.

BMC Neurol. 2013 May 11;13:44. doi: 10.1186/1471-2377-13-44.

2.

Increased Alzheimer's disease neuropathology is associated with type 2 diabetes and ApoE ε.4 carrier status.

Malek-Ahmadi M, Beach T, Obradov A, Sue L, Belden C, Davis K, Walker DG, Lue L, Adem A, Sabbagh MN.

Curr Alzheimer Res. 2013 Jul;10(6):654-9.

3.

Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.

Berg L, McKeel DW Jr, Miller JP, Storandt M, Rubin EH, Morris JC, Baty J, Coats M, Norton J, Goate AM, Price JL, Gearing M, Mirra SS, Saunders AM.

Arch Neurol. 1998 Mar;55(3):326-35.

PMID:
9520006
4.

Apolipoprotein E allelotype is associated with neuropathological findings in Alzheimer's disease.

Kumar NT, Liestøl K, Løberg EM, Reims HM, Mæhlen J.

Virchows Arch. 2015 Aug;467(2):225-35. doi: 10.1007/s00428-015-1772-1. Epub 2015 Apr 22.

PMID:
25898889
5.

Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study.

Murray ME, Graff-Radford NR, Ross OA, Petersen RC, Duara R, Dickson DW.

Lancet Neurol. 2011 Sep;10(9):785-96. doi: 10.1016/S1474-4422(11)70156-9. Epub 2011 Jul 27.

6.

Effect of apolipoprotein E genotype on Alzheimer's disease neuropathology in a cohort of elderly Norwegians.

Morris CM, Benjamin R, Leake A, McArthur FK, Candy JM, Ince PG, Torvik A, Bjertness E, Edwardson JA.

Neurosci Lett. 1995 Dec 1;201(1):45-7.

PMID:
8830309
7.

Modification of the relationship of the apolipoprotein E ε4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleep.

Lim AS, Yu L, Kowgier M, Schneider JA, Buchman AS, Bennett DA.

JAMA Neurol. 2013 Dec;70(12):1544-51. doi: 10.1001/jamaneurol.2013.4215.

8.

Apolipoprotein E ε4 Modulates Cognitive Profiles, Hippocampal Volume, and Resting-State Functional Connectivity in Alzheimer's Disease.

Wang X, Wang J, He Y, Li H, Yuan H, Evans A, Yu X, He Y, Wang H.

J Alzheimers Dis. 2015;45(3):781-95. doi: 10.3233/JAD-142556.

PMID:
25624419
9.

APOE E4 is a determinant for Alzheimer type pathology in progressive supranuclear palsy.

Tsuboi Y, Josephs KA, Cookson N, Dickson DW.

Neurology. 2003 Jan 28;60(2):240-5.

PMID:
12552038
10.

Influence of cognitive status, age, and APOE-4 genetic risk on brain FDDNP positron-emission tomography imaging in persons without dementia.

Small GW, Siddarth P, Burggren AC, Kepe V, Ercoli LM, Miller KJ, Lavretsky H, Thompson PM, Cole GM, Huang SC, Phelps ME, Bookheimer SY, Barrio JR.

Arch Gen Psychiatry. 2009 Jan;66(1):81-7. doi: 10.1001/archgenpsychiatry.2008.516.

11.

Impact of sex and APOE4 on cerebral amyloid angiopathy in Alzheimer's disease.

Shinohara M, Murray ME, Frank RD, Shinohara M, DeTure M, Yamazaki Y, Tachibana M, Atagi Y, Davis MD, Liu CC, Zhao N, Painter MM, Petersen RC, Fryer JD, Crook JE, Dickson DW, Bu G, Kanekiyo T.

Acta Neuropathol. 2016 Aug;132(2):225-34. doi: 10.1007/s00401-016-1580-y. Epub 2016 May 14.

12.

Interaction Between Midlife Blood Glucose and APOE Genotype Predicts Later Alzheimer's Disease Pathology.

Bangen KJ, Himali JJ, Beiser AS, Nation DA, Libon DJ, Fox CS, Seshadri S, Wolf PA, McKee AC, Au R, Delano-Wood L.

J Alzheimers Dis. 2016 Jul 6;53(4):1553-62. doi: 10.3233/JAD-160163.

13.

Genetic polymorphisms in sigma-1 receptor and apolipoprotein E interact to influence the severity of Alzheimer's disease.

Huang Y, Zheng L, Halliday G, Dobson-Stone C, Wang Y, Tang HD, Cao L, Deng YL, Wang G, Zhang YM, Wang JH, Hallupp M, Kwok J, Chen SD.

Curr Alzheimer Res. 2011 Nov;8(7):765-70.

PMID:
21605063
15.

APOE, vascular pathology, and the AD brain.

Yip AG, McKee AC, Green RC, Wells J, Young H, Cupples LA, Farrer LA.

Neurology. 2005 Jul 26;65(2):259-65.

PMID:
16043796
16.

Apolipoprotein E-epsilon 2 and Alzheimer's disease: genotype influences pathologic phenotype.

Lippa CF, Smith TW, Saunders AM, Hulette C, Pulaski-Salo D, Roses AD.

Neurology. 1997 Feb;48(2):515-9.

PMID:
9040748
17.

Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease.

Tiraboschi P, Hansen LA, Masliah E, Alford M, Thal LJ, Corey-Bloom J.

Neurology. 2004 Jun 8;62(11):1977-83.

PMID:
15184600
18.

Molecular signatures in post-mortem brain tissue of younger individuals at high risk for Alzheimer's disease as based on APOE genotype.

Conejero-Goldberg C, Hyde TM, Chen S, Dreses-Werringloer U, Herman MM, Kleinman JE, Davies P, Goldberg TE.

Mol Psychiatry. 2011 Aug;16(8):836-47. doi: 10.1038/mp.2010.57. Epub 2010 May 18.

19.

[Expression of apolipoprotein E in Alzheimer's disease and its significance].

He SR, Liu DG, Wang S, Xia YJ.

Zhonghua Bing Li Xue Za Zhi. 2005 Sep;34(9):556-60. Chinese.

PMID:
16468304
20.

Clinically concordant variations of Alzheimer pathology in aphasic versus amnestic dementia.

Gefen T, Gasho K, Rademaker A, Lalehzari M, Weintraub S, Rogalski E, Wieneke C, Bigio E, Geula C, Mesulam MM.

Brain. 2012 May;135(Pt 5):1554-65. doi: 10.1093/brain/aws076. Epub 2012 Apr 19.

Supplemental Content

Support Center